Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies

被引：26

作者：

Cavaletti, Guido ^{[1
]}

Nicolini, Gabriella ^{[1
]}

Marmiroli, Paola ^{[1
]}

机构：

[1] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy

来源：

FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷

关键词：

peripheral neuropathy; antineoplastic drugs; chemotherapy-induced peripheral neurotoxicity; mechanisms; pre-clinical studies; review;

D O I：

10.2741/2945

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Several antineoplastic drugs induce severe toxic damage of the peripheral nervous system and chemotherapy-induced peripheral neurotoxicity (CIPN) can be dose limiting. Moreover, CIPN signs and symptoms can be permanent and severely impair the patients' quality of life even after drug withdrawal. Despite extensive investigation, the exact mechanisms of neurotoxic action at the basis of CIPN are not completely known and it is likely that they can be at least in part different from the mechanisms of antineoplastic action of the drugs. A possible instrument to investigate on this important issue is represented by the evaluation of the effect of compounds used to reduce the toxicity of antineoplastic drugs in preclinical and clinical settings. This review will be focused on the most clinically-relevant neurotoxic antineoplastic drugs and on the results obtained with several different classes of putative neuroprotectants.

引用

页码：3506 / 3524

页数：19

共 132 条

[1] The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons [J].

Adelsberger, H ;

Quasthoff, S ;

Grosskreutz, J ;

Lepier, A ;

Eckel, F ;

Lersch, C .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (01) :25-32

[2] Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by Cisplatin: behavioral, structural and biochemical analysis [J].

Aloe, L ;

Manni, L ;

Properzi, F ;

De Santis, S ;

Fiore, M .

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2000, 86 (1-2) :84-93

[3] NERVE GROWTH-FACTOR PREVENTS TOXIC NEUROPATHY IN MICE [J].

APFEL, SC ;

LIPTON, RB ;

AREZZO, JC ;

KESSLER, JA .

ANNALS OF NEUROLOGY, 1991, 29 (01) :87-90

[4] Mapk activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of Xaliproden [J].

Appert-Collin, A ;

Duong, FHT ;

Degrace, PP ;

Warter, JM ;

Poindron, P ;

Gies, JP .

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (01) :21-31

[5] Vitamin E for prophylaxis against chemotherapy-induced neuropathy - A randomized controlled trial [J].

Argyriou, AA ;

Chroni, E ;

Koutras, A ;

Ellul, J ;

Papapetropoulos, S ;

Katsoulas, G ;

Iconomou, G ;

Kalofonos, HP .

NEUROLOGY, 2005, 64 (01) :26-31

[6] Chemotherapy-induced peripheral neuropathy [J].

Armstrong, T ;

Almadrones, L ;

Gilbert, MR .

ONCOLOGY NURSING FORUM, 2005, 32 (02) :305-311

[7] Update on tubulin-binding agents [J].

Attard, G ;

Greystoke, A ;

Kaye, S ;

De Bono, J .

PATHOLOGIE BIOLOGIE, 2006, 54 (02) :72-84

[8] Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury [J].

Bacich, DJ ;

Wozniak, KM ;

Lu, XCM ;

O'Keefe, DS ;

Callizot, N ;

Heston, WDW ;

Slusher, BS .

JOURNAL OF NEUROCHEMISTRY, 2005, 95 (02) :314-323

[9] Antioxidant vitamins supplementation and mortality:: A randomized trial in head and neck cancer patients [J].

Bairati, Isabelle ;

Meyer, Francois ;

Jobin, Edith ;

Gelinas, Michel ;

Fortin, Andre ;

Nabid, Abdenour ;

Brochet, Francois ;

Tetu, Bernard .

INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (09) :2221-2224

[10] Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine [J].

Bianchi, G ;

Vitali, G ;

Caraceni, A ;

Ravaglia, S ;

Capri, G ;

Cundari, S ;

Zanna, C ;

Gianni, L .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) :1746-1750

← 1 2 3 4 5 6 7 8 9 10 →